Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S4W-19957 · Session 4

How the rare diseases fund will be affected by the new processes for Scottish Medicines Consortium approval of orphan and ultra-orphan medi…

Answered Asked by Dr Richard Simpson Lab Lodged 26 Feb 2014

The question

To ask the Scottish Government how the rare diseases fund will be affected by the new processes for Scottish Medicines Consortium approval of orphan and ultra-orphan medicines.

The answer

Answered by Alex Neil on 6 Mar 2014 · 8 days after it was lodged, on time

As part of work ongoing between Scottish Government and NHSScotland on the financial implications of the change in approach being adopted by the Scottish Medicines Consortium (SMC) consideration is being given as to how the Rare Conditions Medicines Fund will best support the anticipated increase in medicines accepted by the SMC.

In the Official Report

No contribution in the Official Report cites S4W-19957 by reference.